For much of her early career, Shobie Ramakrishnan called Silicon Valley home. GSK’s chief digital and technology officer ...
4d
GlobalData on MSNFDA approves GSK’s Blujepa for uncomplicated UTIsThe US Food and Drug Administration (FDA) has approved GSK’s triazaacenaphthylene antibiotic, Blujepa (gepotidacin), for ...
5d
GlobalData on MSNGSK and UK researchers plan to study Shingrix and dementia risk reduction linkThe study will analyse electronic health records of 65- and 66-year olds from the UK’s National Health Service (NHS).
5d
Pharmaceutical Technology on MSNEMA to review GSK’s Nucala for COPD treatment expansionThe EMA has agreed to review GSK’s application to expand Nucala’s use as an add-on maintenance for individuals with COPD.
GSK said on Tuesday that it is studying a group of more than a million older adults in the UK to examine whether its ...
Global investment firm KKR is in talks to acquire Leixir Dental Laboratory Group from Comvest Investment Partners at a ...
Merck signed a licensing agreement for a heart disease drug with Jiangsu Hengrui Pharmaceuticals worth up to $2 billion.
For much of her early career, Shobie Ramakrishnan called Silicon Valley home. GSK’s chief digital and technology officer (CDTO) worked for years at tech giants like Apple and Salesforce before ...
CureVac N.V. secured funding with GSK amid financial struggles, while a key patent win boosts stock. Click for why my ...
We recently compiled a list of the 10 Stocks with Potential to Rise 1000 Percent. In this article, we are going to take a ...
Varied approaches to remote patient monitoring are in development to close care gaps between patients and rheumatologists, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results